Market revenue in 2023 | USD 71.2 million |
Market revenue in 2030 | USD 94.9 million |
Growth rate | 4.2% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Plaque Modification Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 22.75% in 2023. Horizon Databook has segmented the Saudi Arabia peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
The Saudi Arabia peripheral vascular devices market growth is propelled due to the increasing prevalence of chronic conditions such as diabetes, stroke, and obesity, which are known for elevating the risk of peripheral vascular diseases. Moreover, the rising elderly population in Saudi Arabia is expected to drive the demand for peripheral vascular devices.
For instance, in August 2021, a research initiative undertaken by the National Institutes of Health provided insights into the prevalence of stroke in Saudi Arabia, revealing an incidence rate of 43.8 cases per 100,000 individuals.
The investigation highlighted a notable prevalence of hypertension, stroke, and dyslipidemia, recognized as significant contributors to cardiovascular disease. Despite the substantial impact of these risk factors, there exists a limited awareness regarding these conditions, exacerbating their prevalence.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia peripheral vascular devices market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account